Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis

BACKGROUND: IgA nephropathy (IgAN) is one of the significant contributing factors of end-stage renal disease (ESRD). It is reported that over half of patients with IgAN accompany multiple high-risk factors, which increase the risk of ESRD progression. Studies have shown that immunosuppressive agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tongtong, Wang, Yuyang, Mao, Huimin, Yang, Liping, Zhan, Yongli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909110/
https://www.ncbi.nlm.nih.gov/pubmed/33663060
http://dx.doi.org/10.1097/MD.0000000000024541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909110/
https://www.ncbi.nlm.nih.gov/pubmed/33663060
http://dx.doi.org/10.1097/MD.0000000000024541

Ejemplares similares